Your browser doesn't support javascript.
loading
High central venous saturation after cardiac surgery is associated with increased organ failure and long-term mortality: an observational cross-sectional study.
Balzer, Felix; Sander, Michael; Simon, Mark; Spies, Claudia; Habicher, Marit; Treskatsch, Sascha; Mezger, Viktor; Schirmer, Uwe; Heringlake, Matthias; Wernecke, Klaus-Dieter; Grubitzsch, Herko; von Heymann, Christian.
Afiliación
  • Balzer F; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. felix.balzer@charite.de.
  • Sander M; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. michael.sander@charite.de.
  • Simon M; Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Erlanger Allee 101, 07747, Jena, Germany. mark.simon@med.uni-jena.de.
  • Spies C; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. claudia.spies@charite.de.
  • Habicher M; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. marit.habicher@charite.de.
  • Treskatsch S; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. sascha.treskatsch@charite.de.
  • Mezger V; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. viktor.mezger@charite.de.
  • Schirmer U; Institute of Anaesthesiology Heart and Diabetes Center Nordrhein-Westfalen, University Clinic Ruhr-University Bochum, Georgstrasse 11, 32545, Bad Oeynhausen, Germany. uschirmer@hdz-nrw.de.
  • Heringlake M; Department of Anaesthesiology and Intensive Care Medicine, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. heringlake@t-online.de.
  • Wernecke KD; SOSTANA GmbH, Wildensteiner Straße 27, 10318, Berlin, Germany. wernecke@sostana.de.
  • Grubitzsch H; Department of Cardiovascular Surgery, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. herko.grubitzsch@charite.de.
  • von Heymann C; Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Campus Charité Mitte/Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10098, Berlin, Germany. christian.von_heymann@charite.de.
Crit Care ; 19: 168, 2015 Apr 16.
Article en En | MEDLINE | ID: mdl-25888321
ABSTRACT

INTRODUCTION:

Central venous saturation (ScvO2) monitoring has been suggested to address the issue of adequate cardiocirculatory function in the context of cardiac surgery. The aim of this study was to determine the impact of low (L) (<60%), normal (N) (60%-80%), and high (H) (>80%) ScvO2 measured on intensive care unit (ICU) admission after cardiac surgery.

METHODS:

We conducted a retrospective, cross-sectional, observational study at three ICUs of a university hospital department for anaesthesiology and intensive care. Electronic patient records of all adults who underwent cardiac surgery between 2006 and 2013 and available admission measurements of ScvO2 were examined. Patients were allocated to one of three groups according to first ScvO2 measurement after ICU admission group L (<60%), group N (60%-80%), and group H (>80%). Primary end-points were in-hospital and 3-year follow-up survival.

RESULTS:

Data from 4,447 patients were included in analysis. Low and high initial measurements of ScvO2 were associated with increased in-hospital mortality (L 5.6%; N 3.3%; H 6.8%), 3-year follow-up mortality (L 21.6%; N 19.3%; H 25.8%), incidence of post-operative haemodialysis (L 11.5%; N 7.8%; H 15.3%), and prolonged hospital length of stay (L 13 days, 9-22; N 12 days, 9-19; H 14 days, 9-21). After adjustment for possible confounding variables, an initial ScvO2 above 80% was associated with adjusted hazard ratios of 2.79 (95% confidence interval (CI) 1.565-4.964, P <0.001) for in-hospital survival and 1.31 (95% CI 1.033-1.672, P = 0.026) for 3-year follow-up survival.

CONCLUSIONS:

Patients with high ScvO2 were particularly affected by unfavourable outcomes. Advanced haemodynamic monitoring may help to identify patients with high ScvO2 who developed extraction dysfunction and to establish treatment algorithms to improve patient outcome in these patients.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxígeno / Mortalidad Hospitalaria / Cuidados Críticos / Catéteres Venosos Centrales / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Care Año: 2015 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxígeno / Mortalidad Hospitalaria / Cuidados Críticos / Catéteres Venosos Centrales / Procedimientos Quirúrgicos Cardíacos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Crit Care Año: 2015 Tipo del documento: Article País de afiliación: Alemania